We were delighted to speak with Dr William Schulyer-Jones (Associate Professor of Medicine, Duke University School of Medicine, Durham, NC, USA) about the findings of the ADAPTABLE STUDY, a large randomized study assessing the benefits and long-term effectiveness of aspirin dosage (81 mg vs. 325mg) for patients with cardiovascular disease.
Abstract title: Aspirin Dosing: A Patient-centric Trial Assessing Benefits And Long-term Effectiveness Trial
Speaker disclosures: Dr Schulyer-Jones has nothing to disclose in relation to this video.
Interview and filming supported by Touch Medical Media. Interview conducted by Nicola Cartridge.
Filmed during a remote video call with Dr Schulyer-Jones as a highlight of ACC 2021, May 2021.
Share this Video
Related Videos In Cardiovascular Disease
Wolfgang Linke, ESC 2021 – Key Pathomechanisms of TTNtv-dilated Cardiomyopathy
Dr Wolfgang Linke (Professor and Chair of Physiology, University Hospital of Münster, Münster, Germany) kindly shared his thoughts on the titin gene TTNtv and dilated cardiomyopathy from the virtual ESC Congress 2021. Questions What is known about the correlation between variants in the titin gene (TTNtv) and the incidence of dilated cardiomyopathy (DCM), and what […]
Stephen Nicholls, ESC 2021 – the HUYGENS Study
Prof. Stephen Nicholls (Professor of Cardiology, Monash University, Melbourne, Australia) kindly shared his thoughts on the impact of PCSK9 inhibitors on lipid-lowering therapy, the effects of statins on coronary atherosclerotic plaques and the HUYGENS study from the virtual ESC Congress 2021. Questions What has been the impact of PCSK9 inhibitors on lipid-lowering therapy, and what […]
Jordan Strom, ESC 2021 – Analysis of the Risks of Moderate and Lesser Aortic Stenosis
Dr Jordan Strom (Director of Echocardiographic Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA) kindly shared his thoughts on his recent analysis of clinical trial and administrative claims data on patients with untreated aortic stenosis from the virtual ESC Congress 2021. Questions What are the aims and scope of your current […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!